Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559545 | PMC |
| http://dx.doi.org/10.1007/s10195-015-0351-1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Administration of anticoagulation strategies for portal vein thrombosis in cirrhosis: network meta-analysis.
Front Pharmacol
January 2025
Center for Evidence-Based Medicine and Clinical Research, Taihe Hospital, Hubei University of Medicine, Shiyan, Hubei, China.
Objectives: Evidences for anticoagulation strategies in cirrhotic with portal vein thrombosis (PVT) are still insufficient. This study aims to comprehensively compare the therapeutic effects of different therapeutic therapeutic measures in individuals suffering from cirrhosis with PVT, with the ultimate goal of providing evidence-based recommendations for thrombolytic therapy in this population.
Methods: Starting from 20 October 2023, a comprehensive search about therapeutic strategies for portal vein thrombosis in cirrhosis was conducted on PubMed, EMBASE, and Cochrane Library.
[Current Management of Patients with Proximal Femur Fractures Receiving Antiplatelet and Anticoagulant Therapy].
Acta Chir Orthop Traumatol Cech
November 2024
II. ortopedicko-traumatologická klinika Lekárskej fakulty Univerzity Komenského a Univerzitnej nemocnice Bratislava.
Article Synopsis
- * The review emphasizes that patients on antiplatelet therapy (like ASA and clopidogrel) don't need to stop their medication before surgery, while those on warfarin should receive vitamin K for reversal to facilitate timely surgery.
- * Direct oral anticoagulants should be paused 24-48 hours pre-surgery, with possible use of antidotes in critical cases, and neuraxial anesthesia can be safely used under certain conditions regarding anticoagulant status.
Epidemiology of Deep Venous Thrombosis Among United States Emergency Departments Over an Eight-Year Period.
Clin Exp Emerg Med
October 2024
Rush University Medical Center Department of Emergency Medicine 1750 W. Harrison St., Kellogg Suite 108 Chicago, IL 60612-3833.
Introduction: Deep vein thrombosis (DVT) is a significant cause of morbidity and mortality worldwide, accounting for substantial healthcare utilization. However, as management strategies have evolved, there is a critical need for current data on incidence, admission rates, and medical management of DVT in the ED setting.
Methods: This cross-sectional study analyzed ED presentations for DVT from 2016-2023 using the Cosmos database.
Atrial fibrillation (AF) is a predominant contributor to morbidity and mortality, and stroke prevention remains the mainstay for the management of AF. The precise mechanism involved in thrombus formation remains unknown. However, factors such as stretch-induced fibrosis, endothelial dysfunction, disordered atrial contractions, and pro-thrombotic states have been postulated for the development of AF.
View Article and Find Full Text PDFReproductive health among women of child-bearing age after surgery for rheumatic heart disease in Rwanda.
J Thorac Cardiovasc Surg
July 2024
Department of Cardiothoracic Surgery, Stanford University, Stanford, Calif.
Objective: To determine maternal and fetal outcomes in postoperative women with rheumatic heart disease who become pregnant after valve surgery and evaluate current anticoagulation management during pregnancy.
Methods: Data from the Rwandan rheumatic heart disease cardiac surgical registry identified all female patients who underwent valve surgery before or during childbearing age since 2006. In total, 136 participants completed a mixed-methods questionnaire detailing each pregnancy after surgery, including anticoagulation regimen and outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!